Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Swedbank in connection with share issues in Brinova Fastigheter
Mandate

Vinge advises Swedbank in connection with share issues in Brinova Fastigheter

December 15, 2016

Vinge advises Swedbank AB (publ) in connection with two share issues in Brinova Fastigheter AB (publ), both a rights issue of shares of class B amounting to approximately SEK 210 million, as well as a share issue of shares of class B to the general public, amounting to approximately SEK 48 million, with deviation from the shareholders pre-emption rights. A prospectus was published on 29 November 2016. Brinova Fastigheter is listed on Nasdaq First North Premier.

Vinge’s team consists of Jesper Schönbeck and Nils Fredrik Dehlin.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026